This company listing is no longer active
Rite Aid Balance Sheet Health
Financial Health criteria checks 0/6
Rite Aid has a total shareholder equity of $-2.0B and total debt of $3.8B, which brings its debt-to-equity ratio to -191.6%. Its total assets and total liabilities are $7.1B and $9.1B respectively.
Key information
-191.6%
Debt to equity ratio
US$3.77b
Debt
| Interest coverage ratio | n/a |
| Cash | US$97.12m |
| Equity | -US$1.97b |
| Total liabilities | US$9.09b |
| Total assets | US$7.13b |
Recent financial health updates
Recent updates
Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan
Oct 16Rite Aid May Be Forced Into Ch.11 Bankruptcy To Resolve Opioid Liabilities
Jul 10Rite Aid Q1 Earnings Preview: Bears Remain In Control
Jun 27Rite Aid names interim CEO as Heyward Donigan departs
Jan 09Rite Aid Q3 2023 Earnings Preview
Dec 20Rite Aid spikes 20% on above average volume
Nov 15Rite Aid partners with Google Cloud on pharmacy insights, customer engagement
Oct 11Financial Position Analysis
Short Term Liabilities: RADC.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: RADC.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: RADC.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: RADC.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if RADC.Q has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if RADC.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.